1st International consensus guidelines for advanced breast cancer (ABC 1)

被引：274

作者：

Cardoso, F. ^{[1
,2
]}

Costa, A. ^{[3
]}

Norton, L. ^{[4
]}

Cameron, D. ^{[5
,6
]}

Cufer, T.

Fallowfield, L. ^{[7
]}

Francis, P. ^{[8
]}

Gligorov, J. ^{[9
]}

Kyriakides, S. ^{[10
]}

Lin, N. ^{[11
]}

Pagani, O. ^{[12
,13
]}

Senkus, E. ^{[14
]}

Thomssen, C. ^{[15
]}

Aapro, M. ^{[16
]}

Bergh, J. ^{[17
]}

Di Leo, A. ^{[18
]}

El Saghir, N. ^{[19
]}

Ganz, P. A. ^{[20
]}

Gelmon, K. ^{[21
]}

Goldhirsch, A. ^{[22
]}

Harbeck, N. ^{[23
]}

Houssami, N. ^{[24
]}

Hudis, C. ^{[25
]}

Kaufman, B. ^{[26
]}

Leadbeater, M. ^{[27
]}

Mayer, M. ^{[28
]}

Rodger, A.

Rugo, H. ^{[29
]}

Sacchini, V. ^{[30
]}

Sledge, G. ^{[31
]}

van't Veer, L. ^{[32
]}

Viale, G. ^{[33
]}

Krop, I. ^{[34
]}

Winer, E. ^{[34
]}

机构：

[1] European Sch Oncol, Lisbon, Portugal

[2] Champalimaud Canc Ctr, Breast Unit, Lisbon, Portugal

[3] European Sch Oncol, IT & Bellinzona, Milan, Switzerland

[4] Mem Sloan Kettering Canc Ctr, Breast Canc Program, New York, NY 10021 USA

[5] Univ Edinburgh, Edinburgh, Midlothian, Scotland

[6] Western Gen Hosp, NHS Lothian, Edinburgh EH4 2XU, Midlothian, Scotland

[7] Univ Sussex, Brighton & Sussex Med Sch, Falmer, England

[8] Peter MacCallum Canc Inst, Div Canc Med, Melbourne, Vic 3000, Australia

[9] Univ Paris 05, Francilian Breast Intergrp Paris, CancerEst APHP Tenon, F-75270 Paris 06, France

[10] Europa Donna Cyprus, Nicosia, Cyprus

[11] Dana Farber Canc Inst, Breast Oncol Ctr, Boston, MA 02115 USA

[12] Oncol Inst So Switzerland, Bellinzona, Switzerland

[13] Breast Unit So Switzerland, Bellinzona, Switzerland

[14] Med Univ Gdansk, Dep Oncol & Radiotherapy, Gdansk, Poland

[15] Univ Halle Wittenberg, Klinikum Krollwitz, Clin Gynaecol, Halle, Saale, Germany

[16] Inst Multidisciplinaire Oncol, Div Oncol, Genolier, Switzerland

[17] Karolinska Inst, Dep Oncol Pathol, Stockholm, Sweden

[18] Osped Misericordia & Dolce, Prato, Italy

[19] Amer Univ Beirut, Med Ctr, NK Basile Canc Inst Breast Ctr Excellence, Beirut, Lebanon

[20] Jonsson Comprehens Canc Ctr, Div Canc Prevent & Control Res, Los Angeles, CA 90034 USA

[21] BC Canc Agcy, Vancouver, BC, Canada

[22] European Inst Oncol, Dep Med, Milan, Italy

[23] Univ Munich, Brustzentrum, Munich, Germany

[24] Univ Sydney, Screening & Test Evaluat Program, Sch Publ Hlth, Sydney Med Sch, Sydney, NSW 2006, Australia

[25] Mem Sloan Kettering Canc Ctr, Breast Canc Med Serv, New York, NY 10021 USA

[26] Chaim Sheba Med Ctr, Tel Hashomer, Israel

[27] Breast Canc Care, London, England

[28] AdvancedBC Org, New York, NY USA

[29] UCSF Helen Diller Family Comprehens Canc Ctr, Dept Med, Breast Oncol Program, San Francisco, CA USA

[30] Mem Sloan Kettering Canc Ctr, Breast Serv, New York, NY 10021 USA

[31] Indiana Univ, Med Ctr, Indianapolis, IN USA

[32] UCSF Helen Diller Family Comprehens Canc Ctr, Breast Oncol Program, San Francisco, CA USA

[33] Univ Milan, I-20122 Milan, Italy

[34] Dana Farber Canc Inst, Breast Oncol Ctr, Boston, MA 02115 USA

来源：

BREAST | 2012年 / 21卷 / 03期

关键词：

Advanced breast cancer; Metastatic breast cancer; Guidelines; Consensus; ABC; 1; BRAIN RADIATION-THERAPY; QUALITY-OF-LIFE; STEREOTACTIC RADIOSURGERY; AROMATASE INHIBITOR; 1ST-LINE TREATMENT; PHASE-III; SINGLE METASTASES; LOW-RESOURCE; CHEMOTHERAPY; SURVIVAL;

D O I：

10.1016/j.breast.2012.03.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The 1st international Consensus Conference for Advanced Breast Cancer (ABC 1) took place on November 2011, in Lisbon. Consensus guidelines for the management of this disease were developed. This manuscript summarizes these international consensus guidelines. (C) 2012 Elsevier Ltd. All rights reserved.

引用

页码：242 / 252

页数：11

共 112 条

[51] Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 [J].

Goldhirsch, A. ;

Wood, W. C. ;

Coates, A. S. ;

Gelber, R. D. ;

Thuerlimann, B. ;

Senn, H. -J. .

ANNALS OF ONCOLOGY, 2011, 22 (08) :1736-1747

[52] Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens [J].

Griggs, Jennifer J. ;

Culakova, Eva ;

Sorbero, Melony E. S. ;

Poniewierski, Marek S. ;

Wolff, Debra A. ;

Crawford, Jeffrey ;

Dale, David C. ;

Lyman, Gary H. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18) :2522-2527

[53]

Guan Zhong-zhen, 2010, 2010 CTRC AACR SAN A

[54] Grading strength of recommendations and quality of evidence in clinical guidelines -: Report from an American College of Chest Physicians task force [J].

Guyatt, G ;

Gutterman, D ;

Baumann, MH ;

Addrizzo-Harris, D ;

Hylek, EM ;

Phillips, B ;

Raskob, G ;

Lewis, SZ ;

Schünemann, H .

CHEST, 2006, 129 (01) :174-181

[55] Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment [J].

Hadji, P. ;

Aapro, M. S. ;

Body, J. J. ;

Bundred, N. J. ;

Brufsky, A. ;

Coleman, R. E. ;

Gnant, M. ;

Guise, T. ;

Lipton, A. .

ANNALS OF ONCOLOGY, 2011, 22 (12) :2546-2555

[56] American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer [J].

Harris, Lyndsay ;

Fritsche, Herbert ;

Mennel, Robert ;

Norton, Larry ;

Ravdin, Peter ;

Taube, Sheila ;

Somerfield, Mark R. ;

Hayes, Daniel F. ;

Bast, Robert C., Jr. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) :5287-5312

[57] Selecting high priority quality measures for breast cancer quality improvement [J].

Hassett, Michael J. ;

Hughes, Melissa E. ;

Niland, Joyce C. ;

Ottesen, Rebecca ;

Edge, Stephen B. ;

Bookman, Michael A. ;

Carlson, Robert W. ;

Theriault, Richard L. ;

Weeks, Jane C. .

MEDICAL CARE, 2008, 46 (08) :762-770

[58] Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer [J].

Hébert-Croteau, N ;

Brisson, J ;

Latreille, J ;

Rivard, M ;

Abdelaziz, N ;

Martin, G .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) :3685-3693

[59]

Houssami N, 2011, ANN ONCOL, DOI [10.1093/annonc/mdr397.32, DOI 10.1093/ANNONC/MDR397.32]

[60] Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor-Positive Metastatic Breast Cancer [J].

Johnston, Stephen ;

Pippen, John, Jr. ;

Pivot, Xavier ;

Lichinitser, Mikhail ;

Sadeghi, Saeed ;

Dieras, Veronique ;

Gomez, Henry Leonidas ;

Romieu, Gilles ;

Manikhas, Alexey ;

Kennedy, M. John ;

Press, Michael F. ;

Maltzman, Julie ;

Florance, Allison ;

O'Rourke, Lisa ;

Oliva, Cristina ;

Stein, Steven ;

Pegram, Mark .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (33) :5538-5546

← 1 2 3 4 5 6 7 8 9 10 →